Panelists considered the technology relatively safe but weren’t swayed by the “statistical gymnastics” needed to find a ...
The outside advisors analyzed the results of the RELIEVE-HF pivotal trial, which randomized 508 patients to either receive ...
J&J is pursuing premarket approval for the heart shunt. Although advisory committees provide recommendations to the FDA, the ...
MedPage Today on MSN
FDA panel on interatrial shunt for heart failure: It's a hard no
An FDA advisory panel gave a unanimous verdict for an interatrial shunt in heart failure: no way.
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) ...
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors—such as empagliflozin (Jardiance) and dapagliflozin (Farxiga)—or ...
“I’ll worry about my heart health when I’m older.” That may be too late, doctors warn. While the average age for being diagnosed with heart disease in the United States is typically in the mid-60s for ...
Having trouble falling asleep? Hang on before reaching for the melatonin. A new study says chronic use of the sleep aid may lead to heart failure — but experts say you shouldn’t panic just yet. While ...
Former Vice President Dick Cheney battled heart disease for most of his adult life, a life extended thanks in part to a heart transplant in 2012. Cheney, who died Monday due to complications of ...
Share on Pinterest A new study raises concerns over long-term melatonin use and cardiovascular risks. Viktoriya Skorikova/Getty Images Researchers say people with insomnia who use melatonin ...
Long-term use of melatonin supplements may be linked with a higher risk of heart failure, according to new research — but does that mean people taking it as a sleep aid should stop using it now? In a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results